TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Vistin Pharma AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
429,031
|
435,391
|
287,675 |
| Financial expenses |
15,773
|
33,984
|
11,279 |
| Earnings before taxes |
84,972
|
62,343
|
-3,635 |
| Total assets |
375,980
|
395,181
|
404,516 |
| Current assets |
134,223
|
162,664
|
157,747 |
| Current liabilities |
195,058
|
221,845
|
279,114 |
| Equity capital |
174,320
|
106,448
|
54,178 |
| - share capital |
100
|
100
|
100 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
46.4%
|
26.9%
|
13.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
19.8%
|
14.3%
|
-1.3% |
| Return on assets (ROA) |
26.8%
|
24.4%
|
1.9% |
| Current ratio |
68.8%
|
73.3%
|
56.5% |
| Return on equity (ROE) |
48.7%
|
58.6%
|
-6.7% |
| Change turnover |
-6,360
|
147,716
|
11,863 |
| Change turnover % |
-1%
|
51%
|
4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.